This is an unprecedented time. It is the dedication of healthcare workers that will lead us through this crisis. Thank you for everything you do.

      Calc Function

    • Calcs that help predict probability of a diseaseDiagnosis
    • Subcategory of 'Diagnosis' designed to be very sensitiveRule Out
    • Disease is diagnosed: prognosticate to guide treatmentPrognosis
    • Numerical inputs and outputsFormula
    • Med treatment and moreTreatment
    • Suggested protocolsAlgorithm

    Disease

    Select...

    Specialty

    Select...

    Chief Complaint

    Select...

    Organ System

    Select...

    Patent Pending

    Embolic Stroke of Undetermined Source (ESUS) Criteria

    Diagnoses embolic stroke of undetermined source.

    INSTRUCTIONS

    Use in patients with ischemic stroke only, not hemorrhagic stroke.

    When to Use
    Pearls/Pitfalls
    Why Use

    Patients with ischemic stroke of unclear etiology.

    • Diagnosis of ESUS can be established after sufficient evaluation, including long-term cardiac monitoring for ≥24 hours, for occlusive large vessel atherosclerosis and high-risk cardioembolic sources in nonlacunar infarcts.
    • Potential low-risk embolic sources are thought to comprise ESUS.
    • Transesophageal echocardiography (TEE) is not required in ESUS; thus, aortic arch atherosclerosis (shaggy aorta) evaluation is not included. 
    • Studies used to develop ESUS were in predominantly Caucasian populations.
    • An unknown proportion of ESUS patients may have non-embolic stroke mechanisms.
    • Defines cryptogenic stroke based on criteria, rather than from the absence of available test results.
    • Outlines sufficient diagnostic workup in ischemic strokes of unclear etiology not previously described.
    • The prior TOAST stroke classification, a diagnosis of exclusion, classifies a high proportion of strokes as cryptogenic.
    • Enables standardized diagnostic criteria for clinical trials.
    • Used in many ongoing randomized controlled trials studying secondary stroke prevention in patients with cryptogenic strokes.
    All 4 must be present:

    Diagnostic Result:

    Please fill out required fields.

    Next Steps
    Evidence
    Creator Insights
    Dr. Robert G. Hart

    About the Creator

    Robert G. Hart, MD, is a professor of medicine and neurology at McMaster University in Hamilton, Ontario, Canada. He also serves as co-director of the McMaster/Hamilton Health Sciences Stroke Fellowship Program and previously directed the stroke program at the University of Texas Health Sciences Center for 25 years. Dr. Hart's research interests include stroke prevention, stroke risk in atrial fibrillation, and novel stroke therapies.

    To view Dr. Robert G. Hart's publications, visit PubMed

    Are you Dr. Robert G. Hart? Send us a message to review your photo and bio, and find out how to submit Creator Insights!
    MDCalc loves calculator creators – researchers who, through intelligent and often complex methods, discover tools that describe scientific facts that can then be applied in practice. These are real scientific discoveries about the nature of the human body, which can be invaluable to physicians taking care of patients.
    Content Contributors
    Reviewed By
    • Cen Zhang, MD
    About the Creator
    Dr. Robert G. Hart
    Are you Dr. Robert G. Hart?
    Content Contributors
    Reviewed By
    • Cen Zhang, MD